Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × treosulfan × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4 Myeloid 3 Lymphoid 2 Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Prednisone 120 Docetaxel 115 enzalutamide 96 pembrolizumab 94 Sunitinib 86 Leuprolide 83 Abiraterone Acetate 83 Gemcitabine 75 Nivolumab 74 bicalutamide 54 Radiotherapy 54 Bevacizumab 54 Goserelin 53 Cisplatin 52 Everolimus 49 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 45 Magnetic Resonance Spectroscopy 45 Sorafenib 40 Carboplatin 39 Paclitaxel 36 atezolizumab 34 Radiosurgery 34 pazopanib 32 Ipilimumab 32 cabozantinib 30 abiraterone 29 Cyclophosphamide 29 Axitinib 29 avelumab 27 Radiation 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00427999 2016-11-21

INV342

Novartis

Phase 2 Completed

67 enrolled 6 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡